Celgene provides Safety Data Sheets (SDSs) for its marketed drug products.
Safety Data Sheets
| Visit Websites ? | Safety Data Sheets | ||
|---|---|---|---|
| Abraxane? (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) | Patent Information | ||
| Idhifa? (enasidenib) | Patent Information | ||
| Inrebic? (fedratinib) | Patent Information | ||
| Istodax? (romidepsin) - Vial 1 | Patent Information | ||
| Istodax? (romidepsin) - Vial 2 | Patent Information | ||
| Onureg? (azacitidine tablets) | Patent Information | ||
| Pomalyst? (pomalidomide) | Patent Information | ||
| Reblozyl? (luspatercept-aamt) | Patent Information | ||
| Revlimid? (lenalidomide) | Patent Information | ||
| Thalomid? (thalidomide) | Patent Information | ||
| Vidaza? (azacitidine) | Patent Information | ||
| Zeposia? (ozanimod) | Patent Information | ||
ABRAXANE?, IDHIFA?, INREBIC?, ISTODAX?, POMALYST?, REBLOZYL?, REVLIMID?, THALOMID?, VIDAZA?, ZEPOSIA? are registered trademarks of Celgene Corporation. IDHIFA? is licensed from Agios Pharmaceuticals, Inc. These products may not be approved and/or licensed in all countries where this website is accessible. For information about Celgene products and services in countries other than the U.S., please contact the local office (as listed in Global Office Network under About). | |||